Nuveen’s Acumen Pharmaceuticals ABOS Stock Holding History

Nuveen’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$169K	Buy	+63,355	New	+$157K	﹤0.01%	3666
2025 Q2	–	Sell	-78,446	Closed	-$86.3K	–	3274
2025 Q1	$86.3K	Hold	78,446	–	–	﹤0.01%	3227
2024 Q4	$135K	Hold	78,446	–	–	﹤0.01%	3265
2024 Q3	$195K	Buy	78,446 +21,782	+38%	+$59.1K	﹤0.01%	3228
2024 Q2	$137K	Buy	+56,664	New	+$180K	﹤0.01%	3283
2022 Q2	–	Sell	-39,241	Closed	-$235K	–	3224
2022 Q1	$235K	Buy	39,241 +26,319	+204%	+$143K	﹤0.01%	3160
2021 Q4	$81K	Hold	12,922	–	–	﹤0.01%	3291
2021 Q3	$192K	Buy	+12,922	New	+$215K	﹤0.01%	3280

Other funds holding ABOS

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KIA

Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Nuveen's ABOS Position: Q2 2026 in Review

Nuveen opened a new position in Acumen Pharmaceuticals (ABOS) in Q2 2026: 63,355 shares worth $169K. The stake represents ﹤0.01% of the portfolio and ranks #3666 among its holdings. This is a return to the name: Nuveen previously reported a position in ABOS as recently as Q1 2025.

Nuveen first reported a position in ABOS in Q3 2021 and has held it in 8 quarters since. The position peaked at $235K in Q1 2022. 96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

Nuveen held 63,355 shares of Acumen Pharmaceuticals worth $169K as of Q2 2026.
Acumen Pharmaceuticals was a new Nuveen position in Q2 2026.
Acumen Pharmaceuticals made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3666 holding.
Nuveen first reported a position in Acumen Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
Nuveen's Acumen Pharmaceuticals position peaked at $235K in Q1 2022.
96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.